Assisted Reproductive Technology (ART) Market Size

Assisted Reproductive Technology (ART) Market Size, Opportunities, Trends, Products, Revenue Analysis, to 2030

Rising demand for Assisted Reproductive Technology procedure such as egg banking, frozen donor services, and IVF among others and increasing incidence of infertility are driving the revenue growth in the ART market.

The Assisted Reproduction (ART) market size is expected to reach USD 39.12 billion by 2030 and register a revenue CAGR of 7.4% during the forecast period, according to the latest report by Reports and Data. Growing demand for surrogacy from the LGBTQIA+ community and rising success rates of in vitro fertilization (IVF) and related ART procedures are driving market revenue growth.

Infertility can be treated with ART. ART helps in the treatment of infertility by providing a range of procedures from which the patient can choose based on the patient’s needs and medical history. The most popular and effective type of ART is in vitro fertilization (IVF).

Donor eggs, donor sperm or frozen embryos are some popular services used by patients in ART. Surrogacy is a major driver of market growth as more and more people overcome the social stigma associated with it and focus on the benefits it provides.

Key companies profiled in the report include:

Cosmos Biomedical Ltd., Microm UK Ltd., CooperSurgical Fertility Solutions, FUJIFILM Irvine Scientific, Cryolab Ltd., Parallabs Ltd., European Sperm Bank, OvaScience, Inc., Bloom IVF and Ferring Pharmaceuticals.

The report is an investigative study that determines the market growth and market scope based on market trends, changes in consumer behavior, consumption and production patterns, product portfolio offered by the market, growth rate, drivers and restraints, financial position and existing challenges and restraints of the Assisted Reproduction Technology market (ART).

The report details the global production capacity, supply and demand ratio, market dynamics and a comprehensive analysis of the competitive landscape. It provides an industry-wide analysis of the market share of individual players along with their business portfolio, manufacturing and production capacity, product portfolio, business expansion plans, financial position and strategic alliances such as mergers and acquisitions, joint ventures and collaborations, among others.

Regional market bifurcation analyzes key market segments such as North America, Latin America, Europe, Asia Pacific and Middle East & Africa. The report details the market growth, market size, revenue growth, market share, production and consumption, demand and supply, current and emerging trends, and technological developments in each region.

The key geographical regions analyzed in the market report are:

North America (USA, Canada)
Europe (UK, Italy, Germany, France, Rest of EU)
AsiaPacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East and Africa (Saudi Arabia, UAE, South Africa, Rest of MEA)
Assisted Reproductive Technology (ART) Market Segmentation on the basis of Types:

Type Technology Outlook (Revenue, billion USD; 2019-2030)

Artificial insemination
Induction of ovulation
Forward Outlook (Revenue, USD billion; 2019-2030)

Fresh donor
Fresh non-donor
A frozen donor
A frozen donor
Embryo/egg banking
Process Technology Outlook (Revenue, billion USD; 2019-2030)

Fertilization in vitro
IVF with Intracytoplasmic Sperm Injection (ICSI)
IVF without ICSI
Artificial insemination-intrauterine insemination
Frozen Embryo Exchange
End-use Outlook (Revenue, billion USD; 2019-2030)

Fertility clinic
Clinical research

Some key points from the रिपोर्ट ( Assisted Reproductive टेक्नोलॉजी )

In February 2021, TMRW Life Sciences announced the launch of the world’s first automated Cryo sample management solution for eggs and embryos used in IVF procedures. The TMRW platform has been launched at a number of fertility clinics across the US, enabling the management of millions of embryos and eggs used in modern IVF.

The egg/embryo banking segment represented a significantly large share of revenue in 2021. Women are born with a limited number of eggs they can have, and as they age, their eggs dwindle.

They can use their stored eggs to conceive a child at their preferred time.

The Frozen Embryo Replacement (FER) segment accounted for a significantly large revenue share in 2021. Improvements in embryo freezing, particularly the vitrification procedure, have increased the frequency of delayed frozen embryo transfers.

The North America market is expected to grow at a steady rate during the forecast period. This is due to increased public awareness of various fertility alternatives, government support for in-vitro fertilization to counter the social stigma surrounding ART, and other technological and procedural advances.

Thank you for reading our message. For any further query or customization inquiry, kindly contact us to know more. Our team will clear your doubts and ensure that the report is tailored to your requirements.

फॉर मोरे अबाउट Assisted Reproductive Technology.

Leave a Comment